Inside informationEnglish
NFL Biosciences strengthens its clinical leadership by expanding Dr. Yannick Plétan’s role as Chief Medical Officer as part of the acceleration of its clinical development program for NFL-101 in smoking cessation
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- NFL Biosciences
- Filed
- 03/07/2025, 08:29
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 078954_20250703